Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

NCT00543127 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

870

Enrollment

OTHER

Sponsor class

Stopped Unjustified decision of company that funded the trial.

Conditions

Breast Cancer

Interventions

DRUG: Fulvestrant
DRUG: Anastrozole

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]